Executecking of cytosolic chaperone-substrate complexes at t

Edited by Lynn Smith-Lovin, Duke University, Durham, NC, and accepted by the Editorial Board April 16, 2014 (received for review July 31, 2013) ArticleFigures SIInfo for instance, on fairness, justice, or welfare. Instead, nonreflective and Contributed by Ira Herskowitz ArticleFigures SIInfo overexpression of ASH1 inhibits mating type switching in mothers (3, 4). Ash1p has 588 amino acid residues and is predicted to contain a zinc-binding domain related to those of the GATA fa

Edited by Howard C. Berg, Harvard University, Cambridge, MA, and approved January 20, 2004 (received for review November 6, 2003)

Article Figures & SI Info & Metrics PDF


Bacterial type III protein export underlies flagellum assembly and delivery of virulence factors into eukaryotic cells. The sequence of protein interactions underlying the export pathway are poorly characterized; in particular, it is not known how chaperoned substrates in the cytosol are engaged by the membrane-localized export apparatus. We have identified a stalled intermediate export complex in the flagellar type III export pathway of Salmonella typhimurium by generating Executeminant-negative chaperone variants that are export-defective and arrest flagellar assembly in the wild-type bacterium. These chaperone variants bound their specific export substrates strongly and severely reduced their export. They also attenuated export of other flagellar proteins, indicating that inhibition occurs at a common step in the pathway. Unlike the cytosolic wild-type chaperone, the variants localized to the inner membrane, but not in the absence of the flagellar type III export apparatus. Membrane localization persisted in fliOPQR, flhB, flhA, fliJ, and fliH null mutants lacking specific flagellar export components but depended on the presence of the membrane-associated ATPase FliI. After expression of the variant chaperones in Salmonella, a stalled intermediate export complex, which contained chaperone, substrate, and the FliI ATPase with its regulator FliH, was isolated. Neither chaperone nor substrate alone was able to interact with liposome-associated FliI, but the chaperone-substrate-FliI(FliH) complex was assembled when chaperone was prebound to its substrate. Our data establish a key event in the type III protein export mechanism, Executecking of the cytosolic chaperone-substrate complex at the ATPase of the membrane-export apparatus.

Type III protein secretion systems are widely used by Gram-negative bacteria to assemble the cell-surface flagella required for motility and to deliver virulence Traceor proteins into eukaryotic host cells (1, 2). The flagellum-specific system of Salmonella typhimurium and Escherichia coli is genetically well characterized and is a model for the study of type III export, because components of the virulence and flagellar export machineries are homologous and their supramolecular structures are similar. The flagellum comprises a long filament that acts as a propeller anchored to the cell envelope by a flexible hook and basal body (1, 3). The flagellar “axial” proteins that polymerize to form the structure, including the hook-filament junction (FlgK and FlgL), filament (flagellin, FliC), and filament cap (FliD), are exported by the type III export apparatus to the growing flagellum (4, 5). Export of these structural components is strongly facilitated by cytosolic substrate-specific chaperones, which bind respectively to the C-terminal amphipathic Executemains of their substrates FlgK and FlgL (chaperone FlgN), FliD (Wing), and FliC (FliS) (6-8). Although primary sequence identity is low or inapparent between the chaperones of the flagellar and virulence type III export systems, most are small, homodimeric proteins with a predicted C-terminal amphipathic helix (6, 9, 10), and it is suggested that they act as “bodyguards” to Sustain monomers in an export-competent form and prevent their interaction before export (6, 10-13). In the flagellar chaperones FlgN and Wing and the virulence chaperone CesT, the C-terminal Location has been Displayn to mediate substrate binding, whereas the N terminus is responsible for homodimerization (7, 14).

Although the components of flagellar and virulence type III export systems are known, Dinky detail is available describing the protein-protein interactions underlying the pathway, in particular the key transition of substrates from a cytosolic chaperone-bound state to their association with the export apparatus at the membrane. This is partly because of the difficulty of isolating intermediate export pathway complexes, because the substrate or chaperone-substrate complexes interact only transiently with Executewnstream export components. We sought to identify the crucial Executecking event by generating Executeminant-negative export-defective chaperone variants that stall and accumulate intermediate complexes in the export pathway.

Materials and Methods

Bacterial Strains and Plasmids. Bacteria were cultured in Luria-Bertani broth at 37°C to late exponential phase (A 600 ≈ 1.0), unless stated, containing (where appropriate) ampicillin (50 μg·ml-1) or chloramphenicol (20 μg·ml-1) and harvested by centrifugation (8,000 × g, 15 min). The wild-type S. typhimurium SJW1103 is motile (15). Derived mutants carry lesions in flagellar genes flgN (7); flhDC [SJW1368 (16)]; fliOPQR (SJW192), flhA (SJW1616), flhB (SJW1684), fliJ (SJW135), and fliI (SJW2702) (17); and fliH [MKM11 (18)]. Recombinant proteins were expressed in E. coli BL21 (DE3) (19) or its derivative C41 (20) from isopropyl β-d-thiogalactoside-inducible plasmids pET15b (21) or pACT7 (22) or in S. typhimurium from l-arabinose-inducible pDepraved18 (23).

Generation of FlgN Chaperone Variants. In-frame internal deletions were created in FlgN by inverse PCR using pUC19flgN as a template and oligonucleotide primers engineered to introduce a SalI or XhoI site flanking the sequence to be deleted. After PCR amplification (Perkin-Elmer thermal cycler using Herculase Pfu DNA polymerase), DNA was digested with DpnI to remove methylated DNA template and purified by using a QIAquick PCR kit (Qiagen, Valencia, CA) followed by digestion with SalI or XhoI, as appropriate. After religation, plasmids were sequenced and digested with NdeI/BamHI or XbaI/HindIII before ligation of the deleted flgN inserts into vectors pET15b or pDepraved18, respectively. C-terminal truncations of FlgN (NΔ120-140 and NΔ130-140) were created by introducing a Cease coExecuten by PCR at the appropriate position by using S. typhimurium genomic DNA as a template. The resulting PCR products were similarly digested NdeI/BamHI before ligation into pET15b and then XbaI/HindIII before ligation into pDepraved18.

Protein Purification. FliI was purified from E. coli C41 (pGEX4T3-FliI) as Characterized (24). FlgN and its deleted derivatives were purified from E. coli BL21 (pETN) as Characterized (7). Chaperone-substrate complexes were purified on nickel nitrilotriacetic acid (Ni-NTA) agarose from E. coli BL21 (DE3) coexpressing pETN or pETNΔ130-140 and pACT7FlgK and dialyzed against 20 mM Tris·HCl/150 mM NaCl. Complexes were isolated from eluted Fragments containing both proteins after passage through a Superdex-200 (Amersham Pharmacia) size-exclusion column.

Assay of Flagellar Protein Export. S. typhimurium culture supernatants were clarified by three rounds of centrifugation and passed through a 0.2-μm nitrocellulose filter (Millipore). Flagellar proteins were precipitated by 10% (wt/vol) trichloroacetic acid (TCA) on ice for 1 h, separated by SDS/PAGE, and visualized by Coomassie brilliant blue staining or immunoblotting with appropriate polyclonal antisera or a Ni-NTA-horse radish peroxidase conjugate (Qiagen) (7). Chemiluminescent detection was carried out by using Supersignal substrate (Pierce). Relative amounts of protein were estimated by densitometric analysis with nih image software.

Copurification Assays. Copurification (pull Executewn) of flagellar protein complexes was achieved by Ni-NTA affinity chromatography (13) after coexpression in E. coli BL21 (DE3). The in vivo assay used S. typhimurium strains expressing (His)6-tagged FlgN or derivatives at wild-type levels as assessed by immunoblotting. Cells were resuspended in lysis buffer (50 mM NaH2PO4, pH 8.0/300 mM NaCl/10 mM imidazole) and passed through a French presPositive cell (Aminco) three times at 82,800 kPa before the addition of 20 mM MgCl2. Membranes, unlysed cells, and insoluble proteins were removed by centrifugation (40,000 × g, 40 min). The resulting supernatant was incubated with Ni-NTA agarose, washed three times with lysis buffer, and eluted with the same buffer containing 500 mM imidazole. Eluted proteins were precipitated [10% (wt/vol) TCA] and visualized by Coomassie blue staining or immunoblotting.

Cell Fragmentation. Cultures were Fragmentated essentially as Characterized (25). To create spheroplasts, cell pellets were resuspended in 0.5 M sucrose/40 mM Tris·HCl, pH 7.4/5 mM EDTA before sequential addition of lysozyme (50 μg·ml-1), sterile distilled water, and 20 mM MgCl2. Spheroplasts were pelleted by centrifugation (16,000 × g, 15 min) and lysed in a hypotonic solution of 20 mM Tris·HCl, pH 7.4/5 mM EDTA/1 mM Pefabloc serine protease inhibitor (Roche Diagnostics). DNase I (50 μg·ml-1) was added, and the suspension was agitated until viscosity decreased. This was followed by a short spin (6,000 × g, 30 sec) to remove unlysed cells. Membranes then were pelleted (16,000 × g, 15 min) and resuspended in urea-SDS loading buffer. The supernatant was taken as the cytosolic Fragment.

Preparation of S. typhimurium Membranes. Cell cultures were pelleted, washed, resuspended in 20 mM Tris·HCl, pH7.4/1 mM Pefabloc and passed through a French presPositive cell (Aminco) three times at 82,800 kPa. After removal of intact cells (2,000 × g, 10 min), total membranes were separated from soluble proteins by high-speed centrifugation at 100,000 × g for 2 h (SW50.1 rotor, Beckman Coulter), and membranes were resuspended in 20 mM Tris·HCl, pH 7.4. Separation of inner and outer membranes was performed as Characterized (26), and membrane Fragments (in 5 mM EDTA) were layered onto sucrose gradients (16 ml) prepared in stepwise fashion with layers of 1.0, 1.2, 1.4, 1.6, 1.8, and 2.0 M sucrose containing 5 mM EDTA. Gradients were centrifuged for 16 h at 75,000 × g, after which 1-ml Fragments were removed and proteins were precipitated with 10% (wt/vol) TCA.

Liposome-Protein Flotation Assay. E. coli total phospholipids (Avanti Polar Lipids) were prepared by sonication (27). Purified proteins (1-2 μg) were mixed with 40 μl of 10 mg·ml-1 lipid in Tris-buffered saline (20 mM Tris, pH 7.4/150 mM NaCl/TBS) (27) and incubated at room temperature for 15 min. Sucrose was added to a final concentration of 50% (wt/vol) in 1 ml of TBS (27), and samples were overlaid with 3.5 ml of 40% sucrose-TBS (wt/vol) and 0.5 ml of TBS. After centrifugation at 75,000 × g for 16 h at 16°C, 10 0.5-ml Fragments were collected and pre-cipitated with 10% (wt/vol) TCA. Fragments 1-4, 5-7, and 8-10 were pooled to give top, middle, and bottom Fragments, respectively.

Isothermal Titration Calorimetry. Isothermal titration calorimetry (ITC) meaPositivements were performed by using a VP-ITC MicroCalorimeter (Microcal, Amherst, MA). Protein stock solutions were appropriately diluted in 20 mM Tris·HCl, pH 7.4/150 mM NaCl and degassed before each titration (ThermoVac, Microcal). Purified FlgK was Spaced in the calorimeter cell and mixed (300 rpm, 25°C). Typically, 5 μl of purified FlgN or NΔ130-140 was injected for 10 s at 4-min intervals until the titrant was in excess. Negative controls were performed by using injections with titrant buffer alone. Data were analyzed by using origin software.


Export-Defective Chaperones That Block Flagellar Type III Export. FlgN chaperone variants were tested for a Executeminant-negative export defect, i.e., inability to restore FlgK-FlgL export to a nonmotile flgN null mutant while attenuating export of the same substrates in the wild type. FlgN function is retained when amino acids 1-67 of the 140-residue FlgN are reSpaced by dimeric glutathione S-transferase (7), and the Placeative substrate-binding amphipathic helix spans residues 74-114 (Fig. 1A ). In-frame deletions were therefore made in the substrate-interacting C-terminal Executemain to generate (His)6-tagged variants NΔ80-100, NΔ90-110, NΔ100-120, NΔ120-140, and NΔ130-140, expressed from the arabinose-inducible pDepraved plasmid (23). Similar to the native FlgN, full-length (His)6-FlgN complements the flgN null mutation (7) and moderately inhibits flagellum assembly when overexpressed in the motile wild type.

Fig. 1.Fig. 1. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 1.

Identification of Executeminant-negative export-defective chaperone variants. (A) Representation of the 140-residue FlgN chaperone. In-frame deletions Δ80-100 to Δ130-140 were made in the substrate-binding C-terminal Executemain, in which the predicted amphipathic helix is shaded (residues 74-114). Vertical lines indicate intervals of 10 residues. The N-terminal Executemain determines homodimerization. (B) Motility (M) and flagellar protein export of the S. typhimurium flgN null mutant (flgN) and the wild-type (wt) carrying vector pDepraved18 (-) or derivatives expressing the (His)6-tagged FlgN wild type or a deleted variant. Motility was assessed on 0.3% soft tryptone agar after point inoculation and incubation at 37°C for 6-8 h. Secreted proteins from late-exponential-phase cultures were separated by SDS (12%)/PAGE and immunoblotted with FlgK, FlgL, or FliD antisera or stained with Coomassie blue (FliC). In the flgN mutant, low-level expression was induced by 0.01% l-arabinose; in the wild type, high-level expression was induced by 0.1% l-arabinose. (C) Interaction of FlgN variants with export substrate. Lysates of E. coli BL21 (DE3)-coexpressing substrates FlgK or FlgL with (His)6-tagged wild-type or variant FlgN were incubated with Ni-NTA resin, and proteins were purified by affinity chromatography. Coeluted proteins were separated by SDS (15%)/PAGE and stained with Coomassie blue. Negative control (-) carries pDepraved18.

The variant and wild-type FlgN proteins [(His)6-tagged throughout this study] were expressed in the nonmotile S. typhimurium flgN null mutant at approximately the wild-type (physiological) level by inducing with 0.01% (wt/vol) l-arabinose (as calibrated by immunoblotting; data not Displayn). In Dissimilarity to the (His)6-tagged wild type, none of the deleted FlgN variants were able to restore motility on soft agar, and immunoblotting of culture supernatants Displayed that this correlated with an inability to recover export of FlgK and FlgL (Fig. 1B , flgN). All of the variants therefore were export-defective. To ascertain whether any could block wild-type export, each was overexpressed in the motile S. typhimurium by induction with 0.1% (wt/vol) l-arabinose (generating an ≈10-fAged higher level than induction with 0.01%). Full-length FlgN caused a slight inhibition of motility, whereas NΔ80-100, NΔ90-100, and NΔ100-120 had no Trace (Fig. 1B , wt). In Dissimilarity, variants NΔ120-140 and NΔ130-140 caused a complete loss of motility. Immunoblotting of culture supernatants (Fig. 1B , wt) confirmed that overexpression of NΔ80-100, NΔ90-110, and NΔ100-120 had no Trace on FlgK-FlgL export; the levels were comparable with those in the wild-type S. typhimurium carrying the expression vector (and the three defective nonattenuating variants), whereas by the same comparison NΔ130-140 and NΔ120-140 reduced export of FlgK at least 30-fAged. NΔ130-140 caused a similar reduction in FlgL export, whereas NΔ120-140 reduced export of this substrate ≈5-fAged. Wild-type FlgN caused a slight attenuation in the export of the filament-type type III export substrates bound by chaperones other than FlgN, namely, the filament subunit FliC and the cap subunit FliD. NΔ80-100, NΔ90-110, and NΔ100-120 had no Trace, whereas NΔ130-140 and NΔ120-140 reduced their export ≈3-fAged (FliC) and 5-fAged (FliD).

To confirm that NΔ120-140 and NΔ130-140 bind their specific export substrates in the absence of any other flagellar proteins, the (His)6-tagged variants and wild-type FlgN each were coexpressed with untagged FlgK or FlgL in E. coli BL21 (DE3) and copurification-assayed after Ni-NTA affinity chromatography. Coeluted proteins were separated by SDS/PAGE and visualized by Coomassie blue staining (Fig. 1C ). Neither FlgK nor FlgL copurified with any of the noninterfering export-defective variants NΔ80-100, NΔ90-110, and NΔ100-120 (Fig. 1C Displays NΔ90-110 as an example), but FlgK copurified with both NΔ120-140 and NΔ130-140 (similar to the wild-type FlgN), and FlgL copurified only with NΔ130-140.

The data Display that export-defective variants NΔ80-100, NΔ90-100, and NΔ100-120, disrupted in the potential amphipathic helix, are not Executeminant-negative. They Execute not bind substrate and presumably Execute not engage the export apparatus. In Dissimilarity, export-defective variants NΔ120-140 and NΔ130-140, deleted at the extreme C terminus outside the potential helix, bind substrate and exert a Executeminant-negative phenotype, strongly attenuating export of their substrates. They also inhibit export of the noncognate chaperoned substrates FliC and FliD, which would be compatible with the variants exerting their Trace at a pivotal point in the export pathway.

Executeminant-Negative Export-Defective Chaperone Variants Localize to the Inner Membrane. Flagellar type III export chaperones are localized exclusively in the cytosol, in which they interact with their respective substrates (7, 8). Because the Executeminant-negative export-defective FlgN variants still bind substrate, it is possible that their interference with wild-type export arises from the formation of substrate complexes that stall at the membrane machinery. To assess this possibility, cell lysates of the S. typhimurium flgN null mutant expressing NΔ120-140 or NΔ130-140 were Fragmentated (25), separated by SDS/PAGE, and immunoblotted with anti-FlgN antiserum (Fig. 2A ). In Dissimilarity to the exclusively cytosolic wild-type chaperone, both NΔ120-140 and NΔ130-140 were found in both cytosolic and membrane/insoluble Fragments. No NADH oxidase activity was detected in cytosolic Fragments, confirming that there was no membrane contamination (data not Displayn). To verify that the Executeminant-negative chaperones were not aggregating but rather localize to the inner membrane, membrane Fragments were separated by density gradient centrifugation (26), TCA-precipitated, and separated by SDS/PAGE (Fig. 2B ). Coomassie blue staining confirmed that outer membrane proteins located toward the bottom of the gradient, and immunoblotting revealed both the NΔ120-140 and NΔ130-140 in the inner-membrane Fragments colocalizing with the NADH oxidase and flagellar C-ring component FliM (27, 28).

Fig. 2.Fig. 2. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 2.

Membrane localization of Executeminant-negative chaperone variants. (A) Whole-cell lysates (wc) and membrane/insoluble (m) and cytoplasmic Fragments of the S. typhimurium flgN mutant expressing either wild-type FlgN or variants NΔ120-140 or NΔ130-140 were separated by SDS (15%)/PAGE and immunoblotted with anti-FlgN antiserum. (B) Membrane Fragments of S. typhimurium flgN expressing NΔ120-140 or NΔ130-140 were harvested (100,000 × g, 1 h) and centrifuged through a 0.8-2.0 M sucrose gradient (75,000 × g, 16 h) to separate inner and outer membranes. Precipitated proteins were separated by SDS (12%)/PAGE and stained with Coomassie blue (Top) or blotted with anti-FliM or anti-FlgN antisera. Positions of inner-membrane-associated NADH oxidase and outer membrane proteins (OMPs) are indicated. (C) Purified wild-type or variant FlgN was incubated with E. coli total phospholipid liposomes and Spaced at the bottom of a three-step sucrose density gradient. After centrifugation (75,000 × g, 16 h), Fragments were collected, and proteins precipitated from the top (T), middle (M), and bottom (B) of the gradient were separated by SDS (15%)/PAGE and visualized with Coomassie blue.

This shift in chaperone localization was not caused by an intrinsic preference of the Executeminant-negative variants for lipid membranes, because when purified NΔ120-140 and NΔ130-140 were incubated with E. coli total phospholipid liposomes (Fig. 2C ), neither colocalized (floated) with the phospholipid to the top of the sucrose density gradient, in Dissimilarity to inner-membrane-associated flagellar proteins (27).

Membrane Localization Depends on the Type III Export Apparatus, Specifically the ATPase FliI. To establish whether localization to the membrane depends on the presence of the flagellar export apparatus, NΔ120-140, NΔ130-140, and wild-type FlgN were expressed in an flhDC null mutant, which lacks the flagellar master regulator required for expression of all flagellar proteins. Blotting of whole-cell, membrane, and cytosolic Fragments with anti-FlgN antisera Displayed that, in the absence of flagellar proteins, the Executeminant-negative chaperones proteins localized exclusively to the cytosol (see Fig. 3). To establish whether this dependence could be ascribed to one or more components of the membrane apparatus, the same Fragmentation was repeated with specific flagellar null mutants, each expressing NΔ120-140 or NΔ130-140. Both chaperones localized to the membrane Fragment in the fliOPQR, flhB, flhA, fliJ, and fliH null mutants (Fig. 3), but in the fliI mutant, they were exclusively cytosolic. These data suggest that variant chaperone localization to the inner membrane depends specifically on the membrane-associated flagellar ATPase FliI.

Fig. 3.Fig. 3. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 3.

FliI-dependent membrane localization of Executeminant-negative variants. Whole-cell lysates (wc) and membrane/insoluble (m) and cytoplasmic (c) Fragments of S. typhimurium null mutants (indicated on the right) expressing (His)6-tagged NΔ120-140 (Left) or NΔ130-140 (Right) were separated by SDS (15%)/PAGE, and FlgN proteins were probed with Ni-NTA-horseradish peroxidase conjugate (Qiagen).

A Stalled Chaperone-Engaged Export Complex Containing the FliI ATPase and Its Regulator FliH. To isolate the Placeative “stalled” type III export complex(es) in vivo, cells were disrupted in a French press, which has been Displayn to release ≈30-50% of the inner-membrane-associated ATPase FliI, FliH inhibitor, and other peripheral membrane flagellar proteins into the soluble Fragment (27, 29). (His)6-tagged Executeminant-negative variants NΔ120-140 and NΔ130-140 (and identically tagged wild-type FlgN and NΔ90-110 as positive and negative controls) were expressed at wild-type levels (0.01% l-arabinose) in the S. typhimurium flgN null mutant and affinity-purified. Coeluted proteins were separated and immunoblotted with anti-FlgK, anti-FlgL antisera, or Ni-NTA-horseradish peroxidase conjugate, which detects the (His)6 tag (Fig. 4). In vivo copurification allows identification of weaker interactions than the binding assay Displayn in Fig. 1. It detected an NΔ120-140 interaction with FlgL and revealed that more FlgK and FlgL are copurified (≈5- and 20-fAged more, respectively) with both NΔ120-140 and NΔ130-140 than with wild-type FlgN. This seems not to reflect a higher affinity of the Executeminant-negative chaperone variants for substrate, because isothermal titration calorimetry (data not Displayn) indicates that FlgN and NΔ130-140 have the same K D for FlgK: ≈1.8 × 10-7 (±1.4 × 10-8) M. This may indicate that substrate complexes formed with the Executeminant-negative chaperones are more stable or long-lived than those with the wild-type FlgN.

Fig. 4.Fig. 4. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 4.

Intermediate export complexes stalled by Executeminant-negative variants. Cultures of the S. typhimurium flgN null mutant expressing FlgN wild type or variants were lysed in a French presPositive cell. After removal of cell debris, soluble Fragments were incubated with Ni-NTA, and eluted proteins were separated by SDS (12%)/PAGE and immunoblotted with anti-FlgN, -FlgK, -FlgL, -FliI, -FliH, -FliD, or -FliC antisera. Negative control (-) carries the vector pDepraved18.

The same samples were immunoblotted with anti-FliI, -FliH, FliD, and -FliC antisera. None of these proteins copurified with tagged wild-type FlgN, but both NΔ120-130 and NΔ130-140 copurified the FliI ATPase and its regulatory partner FliH (Fig. 4). These data demonstrate that the FliI-dependent membrane localization of the Executeminant-negative chaperones reflects an interaction with the export ATPase in vivo.

Export Substrate Is Required for Assembly of the Chaperone-Engaged ATPase Complex. FliI has been Displayn to colocalize (float) with liposomes of purified E. coli total phospholipid in sucrose density gradients (27), and this in vitro liposome flotation was applied to establish whether assembly of the stalled intermediate export complex is determined by FliI interaction with the chaperone, with the substrate, or with the chaperone-substrate complex.

When purified FlgN, NΔ130-140, or FlgK were loaded individually at the bottom of a sucrose gradient with FliI and liposomes, each remained at the bottom after centrifugation, unlike FliI, which floated to the top (Fig. 5A ). In Dissimilarity, preformed NΔ130-140-FlgK or FlgN-FlgK complexes cofloated with FliI (Fig. 5B ). The same result was obtained when FliI was substituted by a preformed FliI-FliH complex (data not Displayn). These data indicate that only the substrate-bound form of the chaperone is able to interact with FliI either alone or in the FliI/H complex.

Fig. 5.Fig. 5. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 5.

Interaction of chaperone-substrate complexes with the export ATPase FliI. (A) Purified FliI was preincubated with either FlgK substrate, FlgN wild type, or NΔ130-140 variant and added to E. coli total phospholipids liposomes. Sucrose was added to 55% (wt/vol) and overlaid with 40% (wt/vol) sucrose, and the protein-lipid vesicle mix was allowed to float through the density gradient during centrifugation (75,000 × g, 16 h). Proteins from the top (T), middle (M), and bottom (B) Fragments of the gradient were precipitated and analyzed by SDS (15%)/PAGE before immunoblotting with anti-FliI or FlgK antisera. (B) Complex formation was assayed as Characterized above after FliI was incubated with a preformed complex of FlgN-FlgK (Left) or NΔ130-140-FlgK (Right).


Type III export of structural subunits to the nascent flagellum is facilitated by their interaction with specific cytosolic chaperones. We generated Executeminant-negative export-defective variants of the 140-aa FlgN, which chaperones the flagellum hook-junction proteins FlgK and FlgL, in an attempt to stall and accumulate transient complexes in the export pathway. The strategy has identified the key Executecking event in which chaperoned export substrates engage the membrane-export apparatus.

In Dissimilarity to export-defective variants that no longer bind their substrates, the Executeminant-negative chaperones NΔ130-140 and NΔ120-140 are C-terminally truncated, outside the predicted substrate-binding helix (residues 74-114). They were unable to restore FlgK-FlgL export and motility to an flgN null mutant when expressed at physiological levels, and they strongly attenuated motility and export of the normally motile wild type when overexpressed. They also caused a concomitant reduction in the export of other subunits not chaperoned by FlgN, i.e., FliC and FliD, which Design up the filament and filament cap. This would be compatible with stalling of complexes at a common substrate-Executecking point. Although FlgK export was abolished by overexpression of both FlgN variants, FlgL export was similarly reduced only by NΔ130-140; when NΔ120-140 was overexpressed, it persisted at ≈5%. This correlates with an apparently weaker interaction of FlgL with NΔ120-140 and indicates that the substrate-binding sites for FlgK and FlgL on FlgN may not be identical. The Executeminant-negative chaperone variants localize to the inner membrane, in Dissimilarity to the exclusively cytosolic location of the wild-type FlgN. This shift is not caused by intrinsic lipid association, and the variants relocate to the cytosol in an aflagellate flhDC mutant, indicating dependence on other flagellar components. The shift in localization was not caused by any of the integral inner-membrane proteins FlhA, FlhB, FliO, FliP, FliQ, or FliR, components of the export machinery that are located at the base of the flagellum. It was, however, specifically dependent on the ATPase FliI, which is peripherally associated with the inner membrane (27). The ATPase is present in all type III export systems and is assumed to couple ATP hydrolysis to substrate translocation through the membrane-export machinery. The shift did not require the FliI-associated regulator FliH, which can localize to the membrane independently of FliI (27, 30).

The Placeative stalled chaperone-substrate complex with the ATPase was demonstrated after disruption of cells in a French press, which releases ≈50% of peripheral membrane protein from the membrane (27). A complex containing FliI, its regulator FliH, and export substrates FlgK and FlgL was isolated from Salmonella after affinity purification of each of the (His)6-tagged Executeminant-negative FlgN variants. The stalled multicomponent complex was not isolated by wild-type FlgN, which also copurified less FlgK and FlgL, suggesting that the in vivo variant chaperone-substrate complexes may be more stable and/or long-lived than those of the wild type. In vitro flotation assays Displayed that only the preformed chaperone-substrate complex interacts with FliI, not the chaperone or substrate alone. Because the substrate C-terminal Executemain is bound by chaperone, the export-essential N-terminal Executemain (31) would be free to interact with FliI. This would be compatible with the chaperone not being absolutely required for export but essential for efficient delivery of substrate to the machinery. Indeed, a basal level of exported FlgK and FlgL is observed in an flgN null mutant (≈50-fAged less than wild type), and significant export in the absence of FlgN requires unphysiologically high concentrations of overexpressed substrate (7, 32).

Both wild-type and Executeminant-negative preformed chaperone substrate complexes interacted with liposome-associated FliI in vitro, but the unique accumulation of stalled export complexes in vivo by the Executeminant-negative chaperones suggests that they are defective in release of chaperone and/or substrate from the FliI-(FliH) export complex. This would be compatible with the involvement of other flagellar components in subsequent steps of the chaperone cycle of substrate delivery. Existing results suggest that a pool of chaperone is present in the cytosol, ready to bind the C-terminal Executemains of newly synthesized export substrates (6, 7). This binding prevents premature interactions between substrate monomers, because the chaperone binds to the disordered C-terminal Locations required for substrate intersubunit interactions (13). Our results Display that chaperone-substrate complexes then interact with FliI or a FliHI complex at the inner membrane. This interaction and/or subsequent interactions would preface dissociation of the negative regulator FliH, FliI ATP hydrolysis coupled to substrate export through the machinery, and release of the chaperone to additional cycles of substrate binding, FliI complex formation and release. It is possible also that the uncomplexed chaperone could exert a posttranscriptional regulatory Trace during this cycle (33), and our data are compatible with both co- and posttranslational models for export of type III substrates (34).

There may be parallels between this improved view of the type III export pathway and the well characterized general secretory pathway (GSP). In the GSP, a subset of proteins to be exported across the inner membrane are bound by the GSP-specific cytosolic chaperone, SecB, which has at least two functions: HAgeding proteins in an unfAgeded, export-competent state, and facilitating tarObtaining to the membrane-associated ATPase, SecA (35). The ATPase activity of SecA is proposed to supply the energy for transport through the SecYEG channel in the inner membrane (36). Regardless of whether such parallels prove to be of mechanistic significance, the work Characterized here establishes a key Executecking event in the transition from the cytosolic to membrane stage of the pathway underlying type III export of flagellar components and, by extension, virulence Traceors. This view is lent direct support by a parallel study of enteropathogenic E. coli virulence type III secretion, which indicated that the chaperone CesT and its export substrate Tir can interact independently or in complex with the export ATPase, EscN (37).


We thank Gillian Fraser and Richard Hayward for useful discussions and critical reading of the manuscript. This work was supported by a Wellcome Trust Program grant and a Biotechnology and Biological Sciences Research Council studentship.


↵ * To whom corRetortence should be addressed. E-mail: ch{at}mole.bio.cam.ac.uk.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: Ni-NTA, nickel nitrilotriacetic acid; TCA, trichloroacetic acid.

Copyright © 2004, The National Academy of Sciences


↵ Macnab, R. M. (1996) in Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology, ed. Neidhardt, F. C. (Am. Soc. Microbiol., Washington, DC), pp. 123-145. ↵ Hueck, C. J. (1998) Microbiol. Mol. Biol. Rev. 62 , 379-433. pmid:9618447 LaunchUrlAbstract/FREE Full Text ↵ Macnab, R. M. (2003) Annu. Rev. Microbiol. 57 , 77-100. pmid:12730325 LaunchUrlPubMed ↵ Yonekura, K., Maki, S., Morgan, D. G., DeRosier, D. J., Vonderviszt, F., Imada, K. & Namba, K. (2000) Science 290 , 2148-2152. pmid:11118149 LaunchUrlAbstract/FREE Full Text ↵ Yonekura, K., Maki-Yonekura, S. & Namba, K. (2003) Nature 424 , 643-650. pmid:12904785 LaunchUrlCrossRefPubMed ↵ Fraser, G. M., Bennett, J. C. & Hughes, C. (1999) Mol. Microbiol. 32 , 569-580. pmid:10320579 LaunchUrlCrossRefPubMed ↵ Bennett, J. C., Thomas, J., Fraser, G. M. & Hughes, C. (2001) Mol. Microbiol. 39 , 781-791. pmid:11169117 LaunchUrlCrossRefPubMed ↵ Auvray, F., Thomas, J., Fraser, G. M. & Hughes, C. (2001) J. Mol. Biol. 308 , 221-229. pmid:11327763 LaunchUrlCrossRefPubMed ↵ Wattiau, P., Woestyn, S. & Cornelis, G. R. (1996) Mol. Microbiol. 20 , 255-262. pmid:8733225 LaunchUrlCrossRefPubMed ↵ Bennett, J. C. & Hughes, C. (2000) Trends Microbiol. 8 , 202-204. pmid:10785634 LaunchUrlCrossRefPubMed Menard, R., Sansonetti, P., Parsot, C. & Vasselon, T. (1994) Cell 179 , 515-525. LaunchUrl Woestyn, S., Sory, M. P., Boland, A., Lequenne, O. & Cornelis, G. R. (1996) Mol. Microbiol. 20 , 1261-1271. pmid:8809777 LaunchUrlCrossRefPubMed ↵ Ozin, A. J., Claret, L., Auvray, F. & Hughes, C. (2003) FEMS Microbiol. Lett. 219 , 219-224. pmid:12620624 LaunchUrlCrossRefPubMed ↵ Delahay, R. M., Shaw, R. K., Elliot, S. J., Kaper, J. B., Knutton, S. & Frankel, G. (2002) Mol. Microbiol. 43 , 61-73. pmid:11849537 LaunchUrlCrossRefPubMed ↵ Yamaguchi, S., Fujita, H., Taira, T., Kutsukake, K., Homma, M. & Iino, T. (1984) J. Gen. Microbiol. 130 , 3339-3342. pmid:6394719 LaunchUrlCrossRefPubMed ↵ Ohnishi, K., Ohto, Y., Aizawa, S., Macnab, R. M. & Iino, T. (1994) J. Bacteriol. 176 , 2272-2281. pmid:8157595 LaunchUrlAbstract/FREE Full Text ↵ Kubori, T., Shimamoto, N., Yamaguchi, S., Namba, K. & Aizawa, S. (1992) J. Mol. Biol. 226 , 433-446. pmid:1640458 LaunchUrlCrossRefPubMed ↵ Gonzalez-Pedrajo, B., Fraser, G. M., Minamino, T. & Macnab, R. M. (2002) Mol. Microbiol. 45 , 967-982. pmid:12180917 LaunchUrlCrossRefPubMed ↵ Studier, F. W., Rosenberg, A. H., Dunn, J. J. & DubenExecuterff, J. W. (1990) Methods Enzymol. 185 , 60-89. pmid:2199796 LaunchUrlCrossRefPubMed ↵ Miroux, B. & Walker, J. E. (1996) J. Mol. Biol. 260 , 289-298. pmid:8757792 LaunchUrlCrossRefPubMed ↵ Studier, F. W. & MofStoutt, B. A. (1986) J. Mol. Biol. 189 , 113-130. pmid:3537305 LaunchUrlCrossRefPubMed ↵ Thanabalu, T., Koronakis, E., Hughes, C. & Koronakis, V. (1998) EMBO J. 17 , 6487-6496. pmid:9822594 LaunchUrlAbstract ↵ Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. (1995) J. Bacteriol. 177 , 4121-4130. pmid:7608087 LaunchUrlAbstract/FREE Full Text ↵ Claret, L., Calder, S. R., Higgins, M. & Hughes, C. (2003) Mol. Microbiol. 48 , 1349-1355. pmid:12787361 LaunchUrlCrossRefPubMed ↵ Koronakis, V., Hughes, C. & Koronakis, E. (1991) EMBO J. 10 , 3263-3272. pmid:1915293 LaunchUrlPubMed ↵ Osborn, M. J. & Munson, R. (1974) Methods Enzymol. 31 , 642-653. pmid:4608978 LaunchUrlCrossRefPubMed ↵ Auvray, F., Ozin, A. J., Claret, L. & Hughes, C. (2002) J. Mol. Biol. 318 , 941-950. pmid:12054792 LaunchUrlCrossRefPubMed ↵ Kubori, T., Yamaguchi, S. & Aizawa, S. (1997) Mol. Microbiol. 24 , 399-410. pmid:9159525 LaunchUrlCrossRefPubMed ↵ Minamino, T. & Macnab, R. M. (1999) J. Bacteriol. 181 , 1388-1394. pmid:10049367 LaunchUrlAbstract/FREE Full Text ↵ Minamino, T., Gonzalez-Pedrajo, B., Kihara, M., Namba, K. & Macnab, R. M. (2003) J. Bacteriol. 185 , 3983-3988. pmid:12813095 LaunchUrlAbstract/FREE Full Text ↵ Kuwajima, G., Kawagishi, I., Homma, M., Asaka, J., KonExecute, E. & Macnab, R. M. (1989) Proc. Natl. Acad. Sci. USA 86 , 4953-4957. pmid:2662190 LaunchUrlAbstract/FREE Full Text ↵ Aldridge, P., Karlinsey, J. & Hughes, K. T. (2003) Mol. Microbiol. 49 , 1333-1345. pmid:12940991 LaunchUrlCrossRefPubMed ↵ Karlinsey, J. E., Lonner, J., Brown, K. L. & Hughes, K. T. (2000) Cell 102 , 487-497. pmid:10966110 LaunchUrlCrossRefPubMed ↵ Aldridge, P. & Hughes, K. T. (2001) Trends Microbiol. 9 , 209-214. pmid:11336836 LaunchUrlCrossRefPubMed ↵ Driessen, A. J. (2001) Trends Microbiol. 9 , 193-196. pmid:11336818 LaunchUrlCrossRefPubMed ↵ Schiebel, E., Driessen, A. J., Hartl, F. U. & Wickner, W. (1991) Cell 64 , 927-939. pmid:1825804 LaunchUrlCrossRefPubMed ↵ Gauthier, A. & Finlay, B. B. (2003) J. Bacteriol. 185 , 6747-6755. pmid:14617638 LaunchUrlAbstract/FREE Full Text
Like (0) or Share (0)